adenovirus vaccine (PeptiCRAd) (Valo Therapeutics)

N/A

Report date: 2025/01/26 18:56:30

Base Information

Drug Nameadenovirus vaccine (PeptiCRAd) (Valo Therapeutics)

Drug Alias NameT-cell pan-Coronavirus vaccinenon-replicating adenovirus vaccine (PeptiCRAd) (Valo Therapeutics)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionCoronavirus spike glycoprotein stimulants

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFinland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAvalo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesAvalo Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A